Oncolytics Biotech Inc.

0.65
-0.01 (-1.63%)
At close: Mar 03, 2025, 3:59 PM
0.68
3.84%
After-hours: Mar 03, 2025, 05:48 PM EST

Oncolytics Biotech Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99
Cash & Equivalents 34.91M 11.67M 41.26M 31.22M 14.15M 13.7M 11.84M 12.03M 24.02M 14.15M 25.22M 19.32M 32.92M 39.3M 33.98M 7.43M 6.72M 3.49M 3.51M 12.41M 2.64M 8.32M 14.97M 17.62M 4.55M
Short-Term Investments 3.38M 20.47M 1.36M 30.36M 13.06M n/a n/a 2.09M 2.06M 2.03M 2M 1.97M 1.94M 3.61M 1.76M 5.85M 18.5M 24.12M 36.89M 21.51M 18.11M n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 716.22K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets n/a 998K n/a 0.00 -0.00 -0.00 -0.00 -0.00 -0.00 0.00 -0.00 n/a n/a 735.68K 1.00 n/a n/a 5.08M 5.11M 12K 111.42K 5.01M 1.00 n/a n/a
Receivables 15K 521K n/a 89.66K n/a 51.65K 4.8M 54.41K 340.06K n/a n/a 44.98K 55.39K 284.99K 64.79K 86.32K 80.08K 84K 47.39K 47.77K n/a 48.54K 95.32K 137.72K 19.75K
Inventory n/a n/a n/a n/a n/a n/a n/a n/a -0.00 n/a n/a n/a n/a n/a 23.9K n/a n/a n/a 540.37K 250.36K 156.84K n/a 24.19K n/a n/a
Other Current Assets 3.25M 1.7M 2.78M 2.43M 2.71M 700.99K 1.18M 260.84K 506.67K 291.55K 361.74K 331.09K 721.58K 278.93K 507.41K 179.67K 260.3K 638.54K 540.37K 250.37K 156.84K 77.16K -2 39.34K 15.29K
Total Current Assets 38.17M 35.68M 44.9M 33.74M 18.93M 14.45M 17.82M 14.44M 26.92M 16.67M 27.69M 21.67M 35.63M 43.47M 36.34M 13.54M 25.55M 28.34M 40.99M 34.22M 20.97M 8.44M 15.09M 17.8M 4.58M
Property-Plant & Equipment 647K 652K 976.29K 609.13K 727.48K 412.74K 333.44K 319.95K 459.82K 525.38K 532.46K 409.25K 392.11K 226.91K 218.13K 263.93K 201.1K 149.6K 189.86K 5.26M 290.5K 308.94K 211.12K 58.9K 18.29K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 180.75K 5.03M n/a n/a n/a 4.67M 4.21M 3.77M 3.8M 2.56M
Total Long-Term Assets 647K 1.65M 976.29K 609.13K 727.48K 412.74K 333.44K 319.95K 459.82K 525.38K 532.46K 409.25K 392.11K 962.59K 934.35K 444.68K 5.23M 5.23M 5.3M 5.27M 5.08M 9.52M 3.98M 3.86M 2.58M
Total Assets 38.82M 37.33M 45.88M 34.35M 19.66M 14.87M 18.15M 14.76M 27.38M 17.19M 28.22M 22.08M 36.02M 44.43M 37.27M 13.99M 30.78M 33.57M 46.29M 39.49M 26.05M 17.97M 19.07M 21.66M 7.16M
Account Payables 1.08M 2.25M 594K 1.81K 3.17K 1.83M 3.51M 4.07M 2.71M 3.37M 6.01M 7.29M n/a n/a n/a n/a 2.82M 2.62M 1.69M 949.26K 884.93K 1.26M 2.32M 604.89K 86.1K
Deferred Revenue n/a n/a -594K -1.81K -3.17K 927.4K 1.55M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt 133K 216K 294K 248.88K 339.85K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities 3.02M 1.48M 1.8M 2.46M 12.53M 988.72K 178.13K n/a n/a n/a n/a n/a 6.5M 2.5M 4.43M 4.53M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Liabilities 4.24M 3.94M 2.69M 2.71M 12.87M 2.81M 5.23M 4.07M 2.71M 3.37M 6.01M 7.29M 6.5M 2.5M 4.43M 4.53M 2.82M 2.62M 1.69M 949.26K 884.93K 1.26M 2.32M 604.89K 86.1K
Long-Term Debt 290K 157K 361K 153.17K 166.43K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 150K 150K 150K 150K 150K 150K 150K 150K
Other Long-Term Liabilities n/a 6.73M n/a n/a n/a 5.86M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.99 n/a n/a -1 n/a n/a n/a n/a n/a
Total Long-Term Liabilities 7.02M 6.89M 7.09M 6.88M 6.9M 5.86M 4.64M n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.99 150K 150K 150K 150K 150K 797.62K 1.14M 150K
Total Liabilities 11.26M 10.83M 9.78M 9.59M 19.77M 8.67M 9.87M 4.07M 2.71M 3.37M 6.01M 7.29M 6.5M 2.5M 4.43M 4.53M 2.82M 2.77M 1.84M 1.1M 1.03M 1.41M 3.12M 1.74M 236.1K
Total Debt 423K 373K 654.75K 402.06K 506.27K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 150K 150K 150K 150K 150K 150K 150K 150K
Common Stock 430.91M 404.04M 391.35M 356.82M 311.08M 285.19M 271.71M 262.32M 261.32M 237.66M 228.61M 198.16M 177.28M n/a 138.12M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Retained Earnings -446M -418.25M -393.42M -367.11M -344.61M -311.48M -294.45M -278.83M -263.69M -249.97M -231.35M -207.81M -171.44M -138.76M -124.38M -102.56M -80.52M -65.03M -50.73M -37.95M -24.99M -16.45M -10.36M -4.19M -574.46K
Comprehensive Income 544K 662K 387.74K 400.23K 464.1K 607.5K 373.73K 554.06K 760.98K 280.04K 79.7K -57.12K -117.5K -513.84K -450.77K -385.84K 5.35M 4.22M 4.43M 9.7M 5.3M 2.7M 2.5M 2.5M 2.5M
Shareholders Equity 27.56M 26.5M 36.1M 24.75M -107.89K 6.2M 8.28M 10.69M 24.67M 13.82M 22.21M 14.79M 29.52M 41.93M 32.84M 9.45M 27.96M 30.8M 44.45M 38.39M 25.02M 16.56M 15.95M 19.92M 6.93M
Total Investments 3.38M 20.47M 1.36M 30.36M 13.06M n/a n/a 2.09M 2.06M 2.03M 2M 1.97M 1.94M 3.61M 2.36M 5.85M 18.5M 24.12M 36.89M 21.51M 18.11M n/a n/a n/a n/a